Phagenesis Ltd.
http://www.phagenesis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Phagenesis Ltd.
Aimmune Gets $145m From Nestlé To Advance Food Allergy Immunotherapies
With the sizeable investment, Nestlé Health Sciences also gets a three-month right of first negotiation for licensing or partnering to develop any Aimmune candidates, including Phase III AR101 for peanut allergy.
M&A Deals Analysis: Big Bucks Are Back
September M&A deals picked up after a quiet summer with 23 M&A deals recorded, the busiest month of the year so far, which included two major deals closing at $4bn.
New Products In Brief
InSightec, TriVascular and NicOx are among firms with notable recent product approvals or launches.
Start-Up Previews
This Month's Profile Group: Artificial Retinal Devices Help The Blind To See, features profiles of 2C Tech Corp., LambdaVision and Nano Retina. Plus these Start-Ups Across Health Care: Adenovir Pharma, Akrivis Technologies, Emboline and Phagenesis.
Company Information
- Industry
- Medical Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice